Global Bioidentical Hormones Market Size To Grow USD 10.10 Billion By 2030 | CAGR 6.50%
09 mars 2023 13h00 HE
|
SPHERICAL INSIGHTS LLP
New York, United States , March 09, 2023 (GLOBE NEWSWIRE) -- The Global Bioidentical Hormones Market Size to grow from USD 6.20 billion in 2021 to USD 10.10 billion by 2030, at a Compound Annual...
PAOG To Expand CBD Nutraceutical Sales In 2022 And Continue Pharmaceuticals Development
01 févr. 2022 09h42 HE
|
PAO Group, Inc.
Sandusky, OH, Feb. 01, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today republished its 2022 strategic update on the company’s CBD pharmaceutical and nutraceutical development...
PAOG Acquisition To Expand CBD IP Portfolio Scheduled To Close December 3rd
24 nov. 2021 09h15 HE
|
PAO Group, Inc.
Sandusky, OH, Nov. 24, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the acquisition of an exclusive license to patented cannabis extraction process that will expand the...
PAOG Announces Pending Acquisition To Expand CBD IP Portfolio Scheduled For Early December
19 nov. 2021 09h00 HE
|
PAO Group, Inc.
Sandusky, OH, Nov. 19, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company has finalized terms for the acquisition of a license to a patented cannabis extraction...
PAOG New Pharmaceutical Product Developments Could Generate Rapid Revenue Surge
17 nov. 2021 10h10 HE
|
PAO Group, Inc.
Sandusky, OH, Nov. 17, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC PINK: PAOG) today confirmed plans to add multiple new pharmaceutical products to its development pipeline in addition to its...
PAOG Expects To Soon Launch 3rd CBD Nutraceutical Adding To 2021 Revenue Potential
09 nov. 2021 13h03 HE
|
PAO Group, Inc.
Sandusky, OH, Nov. 09, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company is on track to introduce yet a third CBD nutraceutical product by year end. PAOG...
PAOG Adds Bioidentical Synthetic CBD To Research Pipeline
08 nov. 2021 11h42 HE
|
PAO Group, Inc.
Sandusky, OH, Nov. 08, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company adding bioidentical synthetic CBD to its overall research initiative. PAOG...